TOTAL VOLUME:

$154.5b

24H VOL:

$271,200,656

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,922,627,141

420,368

Markets across

40,352

events

MATCHED EVENTS:

4,484

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Abbott Laboratories (ABT) Q3 comparable sales growth?
polymarket

Abbott Laboratories (ABT) Q3 comparable sales growth?

Volume:
$8,034

6% to 8%

 - Polymarket

6% to 8% - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 21, 2026

Closed: Oct 21, 9:32 AM EST

polymarket

Polymarket

View
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
polymarket

6% to 8%

View
100%
40%
Yes 100¢No 0¢
—
N/A
$3,484
N/A
N/A
N/A
Settled
Yes
polymarket

10%+

View
0%
2%
Yes 0¢No 100¢
—
N/A
$1,944
N/A
N/A
N/A
Settled
No
polymarket

4% to 6%

View
0%
2%
Yes 0¢No 100¢
—
N/A
$1,469
N/A
N/A
N/A
Settled
No
polymarket

8% to 10%

View
0%
25%
Yes 0¢No 100¢
—
N/A
$735
N/A
N/A
N/A
Settled
No
polymarket

<4%

View
0%
Yes 0¢No 100¢
—
N/A
$403
N/A
N/A
N/A
Settled
No
Total markets: 5

Description

This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by November 30, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is Abbott Laboratories' official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.

Polymarket

This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by November 30, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is Abbott Laboratories' official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.

Frequently asked questions

On Polymarket, the dashboard for the Abbott Q3 sales growth market tracks the implied probability of different sales growth outcomes, the current trading price, and 24-hour trading volume. Currently, volume is $1,296 and total volume to date is $8,034. The dashboard provides a visual representation of how traders are pricing the likelihood of Abbott exceeding or falling short of various sales growth targets for the third quarter. This allows users to quickly assess market sentiment and identify potential trading opportunities related to this specific event.

Currently, prediction market participants are expressing a view on Abbott’s Q3 sales growth that may differ from consensus analyst expectations. While specific analyst forecasts vary, this market allows for a more nuanced assessment of potential outcomes than a simple ‘over/under’ prediction. The aggregated wisdom of the crowd, as reflected in the trading activity on Polymarket, can provide a unique perspective on the likely performance of Abbott, potentially highlighting areas where the market anticipates stronger or weaker growth than currently projected by financial analysts covering the stock.

On Polymarket, this market is priced through a continuous auction mechanism, where traders buy and sell contracts representing different possible outcomes for Abbott's Q3 sales growth. The price of each contract reflects the market's collective assessment of its probability. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The market price dynamically adjusts based on supply and demand, meaning that as more traders bet on a particular outcome, its price increases, and vice versa. This creates a real-time, probabilistic forecast of the event’s outcome, driven by the incentives of market participants.

This market resolves around Oct 21, 2026, with the outcome confirmed once the official Q3 sales growth figure for Abbott Laboratories is verifiable from credible public reporting. The resolution will be based on the comparable sales growth percentage reported by Abbott in its official Q3 earnings release. Traders will then be paid out based on whether their chosen outcome matches the verified result. The market’s resolution is designed to be objective and transparent, relying on publicly available data to determine the winning outcome.

Several factors could influence trading activity in this market before resolution. Unexpected news regarding Abbott’s product pipeline, regulatory approvals, or major acquisitions could shift market sentiment. Broader economic indicators, such as overall healthcare spending trends or macroeconomic data impacting consumer demand, could also play a role. Finally, any revisions to analyst forecasts for Abbott’s Q3 earnings, or commentary from company management during investor conferences, could trigger significant price movements in this market as traders react to new information.